Rethinking Risk-Benefit Assessment for Phase I Multiple Myeloma Trials

被引：0
|
作者：
Malek, Ehsan [1 ]
Saygin, Caner [2 ]
Ye, Rebecca [3 ]
Kim, Byung-gyu [4 ]
Covut, Fahrettin [1 ]
De Lima, Marcos [1 ]
Driscoll, James J. [5 ]
机构：
[1] Univ Hosp Case Med Ctr, Adult Hematol Malignancies & Stem Cell Transplant, Seidman Canc Ctr, Cleveland, OH USA
[2] Cleveland Clin, Taussig Canc Inst, Cleveland, OH USA
[3] Case Western Reserve Univ, Sch Med, Cleveland, OH USA
[4] Case Western Reserve Univ, Dept Pediat, Case Comprehens Canc Ctr, Cleveland, OH USA
[5] Univ Cincinnati, Coll Med, Canc Ctr, Cincinnati, OH USA
来源：
BLOOD | 2016年 / 128卷 / 22期
关键词：
D O I：
10.1182/blood.V128.22.1146.1146
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1146
引用
收藏
页数：5
相关论文
共 50 条
  • [31] Risk-benefit assessment of natalizumab therapy in multiple sclerosis patients and their treating physicians
    Kraemer, J.
    Kleiter, I.
    Meuth, S. G.
    Kasper, J.
    Koepke, S.
    Gaissmaier, W.
    Heesen, C.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 1014 - 1015
  • [32] Risk-Benefit Analysis of Therapy in Multiple Sclerosis
    Qizilbash, Nawab
    Mendez, Ignacio
    Sanchez de la Rosa, Rainel
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2012, 21 : 448 - 448
  • [33] RISK-BENEFIT ANALYSIS OF THERAPY IN MULTIPLE SCLEROSIS
    Qizilbash, N.
    Mendez, I
    Sanchez-de la Rosa, R.
    [J]. VALUE IN HEALTH, 2011, 14 (07) : A317 - A318
  • [34] RISK-BENEFIT ASSESSMENT OF ANESTHETIC AGENTS IN THE PUERPERIUM
    KANTO, J
    [J]. DRUG SAFETY, 1991, 6 (04) : 285 - 301
  • [35] A risk-benefit assessment of irinotecan in solid tumours
    Siu, LL
    Rowinsky, EK
    [J]. DRUG SAFETY, 1998, 18 (06) : 395 - 417
  • [36] Carbapenems in serious infections - A risk-benefit assessment
    Norrby, SR
    [J]. DRUG SAFETY, 2000, 22 (03) : 191 - 194
  • [37] Risk-benefit assessment of nimesulide urgently needed
    [J]. Reactions Weekly, 2003, 934 (1) : 3 - 3
  • [38] A Risk-Benefit Assessment of Pharmacological Therapies for Hirsutism
    Enrico Carmina
    [J]. Drug Safety, 2001, 24 : 267 - 276
  • [39] A risk-benefit assessment of pharmacological therapies for hirsutism
    Carmina, E
    [J]. DRUG SAFETY, 2001, 24 (04) : 267 - 276
  • [40] A TIERED APPROACH FOR RISK-BENEFIT ASSESSMENT OF FOODS
    Fransen, Heidi
    de Jong, Nynke
    Hendriksen, Marieke
    Mengelers, Marcel
    Castenmiller, Jacqueline
    Hoekstra, Jeljer
    van Leeuwen, Rolaf
    Verhagen, Hans
    [J]. ANNALS OF NUTRITION AND METABOLISM, 2009, 55 : 661 - 661
12345